Carmel Pharma/PhaSeal Exhibiting at Booth #1127 at ASHP MCM
Offerings Include Live Leakproof Integrity Test w/ Industry Thought Leaders, New Product Demos, Nintendo Wii Raffle and More.
Columbus, OH, December 05, 2008 --(PR.com)-- Carmel Pharma, manufacturer of the PhaSeal System for the safe handling of hazardous drugs, will offer several interactive activities at Booth #1127 during the 43rd Annual ASHP Midyear Clinical Meeting, including: live demonstrations of the product comparison “pH Test” led by industry thought leaders, “Ask the Experts” opportunities, new product demos, chances to win a Nintendo Wii and more.
Designed to illustrate the leakproof connection integrity of today’s available vial transfer devices, the pH Test uses ordinary lemon juice (which simulates drug across both preparation and administration manipulations) and litmus strips to determine if there is an occurrence of leakage. In similar tests – including the “Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs” recently published in Hospital Pharmacy – PhaSeal has been the only vial transfer device to meet the leakproof and airtight definition of a CSTD.
Accompanied by Ask the Experts opportunities, the pH test will be conducted on Monday, December 8, from 11am-1pm and on Tuesday, December 9, from 11am-3pm; these demonstrations will be led by Safe Handling Experts Byron Peters, RPh, Director of Pharmacy for Siteman Cancer Center and Tom Carey, PharmD, Director of Pharmacy for SwedishAmerican Hospital. All other booth activities will be ongoing throughout the show.
The 43rd Annual ASHP Midyear Clinical Meeting will be held in Orlando, FL at the Orange County Convention Center Monday, December 8 through Wednesday, December 10. Exhibit hours are Monday and Tuesday from 11am-3pm and Wednesday from 11am-2pm.
PhaSeal is more than a system for the safe handling of hazardous drugs. It’s the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the “Gold Standard” in safe handling, PhaSeal’s airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components make the system easy to use from preparation and administration to waste disposal.
The PhaSeal System is manufactured by Carmel Pharma ab in Gothenburg, Sweden and is distributed from its U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since 2000 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children’s in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit www.phaseal.com or email info@carmelpharmausa.com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today’s clinical thought leaders, please contact Emily Frydendal at 614-318-2635 or emily.frydendal@carmelpharma.com.
###
Designed to illustrate the leakproof connection integrity of today’s available vial transfer devices, the pH Test uses ordinary lemon juice (which simulates drug across both preparation and administration manipulations) and litmus strips to determine if there is an occurrence of leakage. In similar tests – including the “Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs” recently published in Hospital Pharmacy – PhaSeal has been the only vial transfer device to meet the leakproof and airtight definition of a CSTD.
Accompanied by Ask the Experts opportunities, the pH test will be conducted on Monday, December 8, from 11am-1pm and on Tuesday, December 9, from 11am-3pm; these demonstrations will be led by Safe Handling Experts Byron Peters, RPh, Director of Pharmacy for Siteman Cancer Center and Tom Carey, PharmD, Director of Pharmacy for SwedishAmerican Hospital. All other booth activities will be ongoing throughout the show.
The 43rd Annual ASHP Midyear Clinical Meeting will be held in Orlando, FL at the Orange County Convention Center Monday, December 8 through Wednesday, December 10. Exhibit hours are Monday and Tuesday from 11am-3pm and Wednesday from 11am-2pm.
PhaSeal is more than a system for the safe handling of hazardous drugs. It’s the only clinically proven closed-system drug transfer device (CSTD) available today and is validated by more than 10 independent, peer-reviewed, published clinical studies. Distinguished by prominent thought leaders as the “Gold Standard” in safe handling, PhaSeal’s airtight Expansion Chamber and leakproof Double Membrane connections prevent exposure to hazardous drugs, including aerosols and vapors, and make it the only system that meets the National Institute for Occupational Safety and Health (NIOSH) and International Society of Oncology Pharmacy Practitioners (ISOPP) definition of a true CSTD. Its streamlined design and universally-compatible components make the system easy to use from preparation and administration to waste disposal.
The PhaSeal System is manufactured by Carmel Pharma ab in Gothenburg, Sweden and is distributed from its U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since 2000 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children’s in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit www.phaseal.com or email info@carmelpharmausa.com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today’s clinical thought leaders, please contact Emily Frydendal at 614-318-2635 or emily.frydendal@carmelpharma.com.
###
Contact
Carmel Pharma, Inc.
Emily Frydendal
614-318-2635
www.carmelpharma.com
Emily Frydendal
614-318-2635
www.carmelpharma.com
Contact
Categories